A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey

被引:54
|
作者
Ozgoztasi, O [1 ]
Baydar, I [1 ]
机构
[1] GAZIANTEP UNIV,DEPT DERMATOL & INFECT DIS,GAZIANTEP,TURKEY
关键词
D O I
10.1046/j.1365-4362.1997.00022.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
An open-labeled, randomized clinical trial to evaluate the efficacy of paromomycin ointment as compared with ketoconazole was conducted on seventy-two patients of both sexes and different ages with the confirmed diagnosis of cutaneous leishmaniasis (CL). All patients had a complete clinical evaluation for other diseases. Patients were excluded if they were pregnant or nursing or if they had serious concomitant diseases. Patients were divided randomly into two treatment groups: in the first group 40 patients were treated with an ointment containing 15% paromomycin sulfate and 12% methylbenzothonium chloride in white soft paraffin (labeled as p-ointment by El-On(1)) twice daily for 15 days. Treated lesions were left uncovered. The second group consisted of 32 patients who received ketoconazole 400 mg/day orally for 30 days. This dosage was reduced to 200 mg/day for patients below 12 years of age. In all cases the diagnosis was based on positive smear and/or culture. Direct smears were prepared from the exudate obtained by a small incision made at the edge of the lesion with a sterile surgical blade or lancet and stained using the Giemsa method for leishmania bodies (Pig. 1). In smear negative and suspected cases aspirates taken by puncturing the lesions were inoculated onto NNN (Novy, McNeal, Nicolle) medium for culture. The cultures were incubated at 28 degrees C and the development of motile promastigotes was observed. Clinical and parasitological evaluations of the patients were performed at the end of the treatment period and 4 weeks post-treatment. A cure was defined as complete healing and disappearance of the lesion or reversible hypopigmentation at the site of lesion. Incomplete or partial improvement was defined as a reduction in the size of a lesion and the absence of parasites on smear or culture. A treatment failure was defined as the absence of any changes in the lesion and persistence of parasites on smear or culture.
引用
下载
收藏
页码:61 / 63
页数:3
相关论文
共 50 条
  • [31] Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial
    Ola M. Ezzatt
    Iman M. Helmy
    Clinical Oral Investigations, 2019, 23 : 947 - 956
  • [32] RANDOMIZED CLINICAL-TRIAL OF TOPICAL MUPIROCIN VERSUS ORAL ERYTHROMYCIN FOR IMPETIGO
    GOLDFARB, J
    CRENSHAW, D
    OHORO, J
    LEMON, E
    BLUMER, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (12) : 1780 - 1783
  • [33] Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin
    Neva, FA
    Ponce, C
    Ponce, E
    Kreutzer, R
    Modabber, F
    Olliaro, P
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (04) : 473 - 475
  • [34] Cutaneous leishmaniasis (Aleppo boil): Successful treatment with topical paromomycin (Humatin(R))
    AlWakeel, M
    Kiehl, P
    Kapp, A
    Weiss, J
    EUROPEAN JOURNAL OF DERMATOLOGY, 1997, 7 (01) : 47 - 48
  • [35] Topical diclofenac versus oral diclofenac in the treatment of mastalgia - a randomized clinical trial
    Zafar, Afsheen
    Rehnnan, Ahmed
    RAWAL MEDICAL JOURNAL, 2013, 38 (04): : 371 - 377
  • [36] CUTANEOUS LEISHMANIASIS ACQUIRED IN THE US IN A PEDIATRIC PATIENT - THERAPY WITH TOPICAL KETOCONAZOLE
    Singh, M.
    Balan, A.
    Parham, D.
    Weingartner, J.
    Allen, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 418 - 418
  • [37] Topical treatment of persistent cutaneous leishmaniasis with paromomycin [Topische therapie einer persistierenden kutanen leishmaniase mit paromomycin]
    Flaig M.J.
    Rupec J.
    Ruzicka T.
    Rupec R.A.
    Der Hautarzt, 2007, 58 (8): : 689 - 692
  • [38] AMINOSIDINE (PAROMOMYCIN) VERSUS SODIUM STIBOGLUCONATE FOR THE TREATMENT OF AMERICAN CUTANEOUS LEISHMANIASIS
    HEPBURN, NC
    TIDMAN, MJ
    HUNTER, JAA
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (06) : 700 - 703
  • [39] Oral Pentoxifylline Associated with Pentavalent Antimony: A Randomized Trial for Cutaneous Leishmaniasis
    Brito, Graca
    Dourado, Mayra
    Guimaraes, Luiz Henrique
    Meireles, Everson
    Schriefer, Albert
    de Carvalho, Edgar Marcelino
    Lima Machado, Paulo Roberto
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 96 (05): : 1155 - 1159
  • [40] Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia
    del Mar Castro, Maria
    Cossio, Alexandra
    Navas, Adriana
    Fernandez, Olga
    Valderrama, Liliana
    Cuervo-Pardo, Lyda
    Marquez-Onate, Ricardo
    Adelaida Gomez, Maria
    Saravia, Nancy Gore
    PATHOGENS, 2022, 11 (03):